Ottawa, ON – ABcann Global Corporation (TSX-V:ABCN) (“ABcann” or the “Company”) announced that it has amended and extended the research contract currently in place between its Canadian operating subsidiary, ABcann Medicinals Inc., and the University of Guelph, of Guelph, Ontario. The agreement, which dates back to Jan. 1, 2015, has been extended to Dec. 31, […]

A new research study in Vancouver is looking for 1,000 dispensary clients to participate in an online survey to help inform the government ahead of legalization. The B.C. Centre on Substance Use (BCCSU) is examining the benefits and potential harms of dispensaries, ahead of the July 2018 legalization deadline set out by the feds. “We […]

The article states: “The companies are targeting more than 100 million Americans who suffer from chronic pain, and are dependent on opioid painkillers such as Vicodin, or addicted to street opiates including heroin.”  “We are grateful that Reuters is covering companies like AXIM that are developing alternatives for the roughly 2.5 million Americans addicted to […]

Late last week, two new studies received a flurry of news coverage and at first blush appeared contradictory: An insurance-industry nonprofit found that collision claims had increased in states that legalized marijuana compared to others, while a paper published in an academic journal found no link between legalization and traffic fatalities. Both fueled a now-predictable […]

Maryland medical marijuana regulators took steps Monday to deny a license to one of the 15 companies picked to grow the drug, saying there was a “reasonable likelihood” the firm would not properly safeguard the medicine. In voting to tell MaryMed LLC that it would not receive a final license, the Maryland Medical Cannabis Commission […]

DENVER – A recent insurance study links increased car crash claims to legalized recreational marijuana. The Highway Loss Data Institute, a leading insurance research group, said in study results released Thursday that collision claims in Colorado, Washington, and Oregon went up 2.7 percent in the years since legal recreational marijuana sales began when compared with […]

A handful of drugmakers are taking their first steps toward developing marijuana-based painkillers, alternatives to opioids that have led to widespread abuse and caused the U.S. health regulator to ask for a withdrawal of a popular drug this month. The cannabis plant has been used for decades to manage pain and there are increasingly sophisticated […]

Last week, a graphic designer shared a link to a post titled “How Sophisticated Branding Aims to Make You Rethink Cannabis” with Benzinga. The article, published on Adobe Systems Incorporated (NASDAQ: ADBE)’s creative community/blog “99U” explained how distinct branding was key for brand building as the cannabis industry continues to mature. “The hand-painted signs, bad puns, […]

Visit the ABcann Global Investor Dashboard and stay up to date with data-driven, fact based due diligence for active traders and investors. OTTAWA, June 26, 2017 (GLOBE NEWSWIRE) — ABcann Global Corporation (TSXV: ABCN) (OTC: ABCCF) (“ABcann” or the “Company”) is pleased to announce that it has amended and extended the research contract currently in place […]

Cannabinoids are the chemical compounds in marijuana that make you feel high Scientist found that taking pills containing the chemical could stop headaches Pills containing the chemicals reduced pain from migraines by 43.5 per cent And drugs had a number of positive side effects, including fewer stomach aches  By Daisy Dunne For Mailonline Published: 10:32 EDT, […]

By Alicia Wallace, The Cannabist Staff Cannabidiol is a non-psychoactive cannabis compound touted for its medicinal promise — but marijuana- and hemp-derived extracts rich in CBD and low in intoxicating THC are facing a future yet to be determined. The Cannabist’s special report “CBD, TBD” explores a regulatory and legal landscape pockmarked by federal-state conflicts, […]

Cannabis oil is on sale in a number of local chemists and health food shops and is in high demand among the community, particularly those in chronic pain. The product contains cannabidiol (CBD) which was classified as a medicine by the Medicines and Healthcare products Regulatory Agency (MHRA) in December 2016. It does not contain […]